Ticker Symbol: PBLA
Panbela Therapeutics Inc.
$2.17 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
Company Profile
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics, Inc. isdedicated to treating patients with pancreatic cancer and exploring SBP-101's potential for efficacy in combination with other agents and in treating other types of cancer.
Sector: N/A
Industry: N/A
Standard Industrial Classification Code (SIC code): N/A
Address: 712 Vista Blvd # 305
Website: panbela.com
CEO: Michael Cullen
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.17
Change:
-$0.09
(
-7.14%)
Days Range: $1.16 - $1.31
Beta: -
52wk. High: $295.20
52wk. Low: $0.82
Ytd. Change -105.71%
50 Day Moving Average: $1.23
200 Day Moving Average: $5.33
Shares Outstanding: 2957736
Valuation
Market Cap: 346.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A